IgA Nephropathy Insights From Treatment Experience Among Patients Receiving Iptacopan and/or Atrasentan Using Primary Data Collection
Clinical trial NCT07481084 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07481084
- Sponsor
- Novartis Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-05-29
- Primary completion
- 2029-03-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.